Trastuzumab Lyophilized Powder for Infusion Manufacturers

Trastuzumab Lyophilized Powder for Infusion 150mg Manufacturer Supplier in India – Why Taj Pharma is the Leading Exporter Trusted Worldwide

Taj Pharma India, a distinguished pharmaceutical powerhouse based in Vapi, Gujarat, stands tall as the leading manufacturer and supplier of Trastuzumab Lyophilized Powder for Infusion 150mg in India. With a proven track record in oncology formulations, Taj Pharma brings excellence, innovation, and global compliance to the forefront of cancer care solutions. As a premium exporter and PAN India supplier, our Trastuzumab 150mg is a gold standard treatment in HER2-positive breast cancer and metastatic stomach cancer.

What is Trastuzumab Lyophilized Powder for Infusion 150mg?

Trastuzumab Lyophilized Powder for Infusion 150mg is a recombinant DNA-derived humanized monoclonal antibody (IgG1) that targets the HER2/neu receptor, a protein that promotes the growth of cancer cells. It is primarily used for HER2-positive metastatic breast cancer, early-stage breast cancer, and HER2-overexpressing gastric cancer. Administered via intravenous infusion, this drug binds to HER2 receptors on cancer cells, inhibiting their proliferation and inducing antibody-dependent cytotoxicity.

Taj Pharma’s Trastuzumab is formulated with precision, guaranteeing high stability, efficacy, and safety. It’s manufactured under WHO-GMP, EU-GMP, and USFDA-compliant facilities, meeting stringent international standards.

Trastuzumab Lyophilized Powder for Infusion 150mg: Composition and Mechanism

Each vial of Trastuzumab Lyophilized Powder for Infusion 150mg contains 150mg of Trastuzumab as the active pharmaceutical ingredient. It is supplied as a sterile, white to pale yellow lyophilized powder, reconstituted before infusion. The drug works by blocking HER2 receptors, inhibiting the downstream PI3K/Akt and MAPK signaling pathways that promote cancer cell survival and division. This mechanism makes it one of the most effective biological therapies in oncology.

Therapeutic Indications and Usage

Taj Pharma’s Trastuzumab 150mg Infusion is widely prescribed for:

HER2-Positive Metastatic Breast Cancer: Alone or in combination with paclitaxel or docetaxel.
Early Breast Cancer (EBC): Adjuvant treatment post-surgery or with chemotherapy.
HER2-Positive Gastric Cancer: In combination with capecitabine or 5-FU and cisplatin.

It has transformed the prognosis of HER2-positive patients globally, significantly increasing overall survival (OS) and disease-free survival (DFS).

Unmatched Quality and Purity: Why Taj Pharma is the Best Choice

As a trusted name in Indian and international pharma exports, Taj Pharma has built its legacy through:

✔ Stringent Quality Assurance: From raw material sourcing to final packaging, our QMS ensures 100% regulatory compliance.
✔ Global Compliance Certifications: Our facilities are WHO-GMP, ISO 9001:2015, and EU-GMP certified, ensuring credibility across regulated markets.
✔ Research-Driven Manufacturing: Our R&D infrastructure constantly innovates for formulation optimization and biosimilarity accuracy.
✔ Competitive Pricing: Despite the high complexity of biologics, we offer cost-effective Trastuzumab 150mg without compromising quality.
✔ Dedicated Regulatory Support: From dossier preparation to export documentation, we help partners navigate compliance with ease.

Side Effects and Precautions

While Trastuzumab 150mg is life-saving, patients may experience side effects such as fever, chills, nausea, weakness, diarrhea, cough, breathlessness, and cardiac dysfunction. Healthcare providers are advised to monitor cardiac function via echocardiograms before and during treatment.

Patients should avoid pregnancy while on Trastuzumab and use reliable contraception methods throughout the treatment and for at least 7 months post-treatment.

Taj Pharma’s Global Reach: Exporting Oncology Excellence

Taj Pharma is not just a Trastuzumab Lyophilized Powder 150mg Manufacturer in India, but a trusted global exporter catering to:

✓ Africa: Nigeria, Kenya, Ghana, South Africa, Egypt
✓ Middle East: UAE, Saudi Arabia, Iraq, Jordan, Oman
✓ LATAM: Brazil, Argentina, Peru, Colombia, Mexico
✓ CIS & Eastern Europe: Ukraine, Russia, Kazakhstan
✓ Southeast Asia: Philippines, Vietnam, Malaysia, Indonesia

With decades of experience, we have forged long-standing relationships with government tenders, hospital chains, oncology clinics, and pharmaceutical importers.

Trastuzumab Lyophilized Powder for Infusion 150mg Product Specifications

Product NameTrastuzumab Lyophilized Powder for Infusion 150mg
Brand NameTaj Pharma or Custom Branding for PCD Clients
FormulationLyophilized Powder for IV Infusion
Strength150mg/vial
RouteIntravenous (IV)
Storage2°C to 8°C (Do not freeze)
PackingSingle-use vial with sterile diluent
CertificationsWHO-GMP, EU-GMP, ISO 9001:2015, NDA, USFDA guidelines
Export MarketsAfrica, Middle East, LATAM, Southeast Asia, CIS
Shelf Life36 Months

PCD Pharma Franchise & Third-Party Manufacturing

Taj Pharma offers attractive PCD franchise opportunities and contract manufacturing services for Trastuzumab Lyophilized Powder for Infusion 150mg. Our franchise partners enjoy:

☑ Monopoly Rights
☑ Promotional Material Support
☑ Fastest Turnaround Manufacturing Times
☑ Exclusive Branding Opportunities
☑ Transparent Business Terms

Whether you are a distributor, importer, or hospital procurement head, Taj Pharma delivers unmatched flexibility, quality, and support.

Why Choose Taj Pharma for Trastuzumab Lyophilized Powder for Infusion 150mg?

🔹 Legacy of Trust: Over two decades of global presence in oncology manufacturing.
🔹 Advanced Biopharma Facilities: Fully integrated plant with aseptic filling, lyophilization, and biologics-grade cleanrooms.
🔹 Speedy Delivery: Pan-India dispatch network and global logistics coordination.
🔹 Custom Packaging: Private labelling and multi-lingual pack inserts available.
🔹 Strong Ethical Commitment: Our mission is to make lifesaving treatments affordable and accessible.

Taj Pharma’s Role in the Fight Against Cancer

As one of the top Trastuzumab manufacturers in India, we are deeply committed to the battle against cancer. Our oncology product line includes biosimilars, cytotoxics, hormonal therapies, and immunotherapies, covering multiple tumor types. We invest continually in clinical trials, pharmacovigilance, and product lifecycle enhancement.

With Trastuzumab 150mg, we are bridging the affordability gap, especially in low and middle-income countries (LMICs), empowering healthcare providers to offer international-standard treatments at a fraction of the cost.


📞 Contact Us Today

Partner with one of the most reliable pharmaceutical companies in India. For Trastuzumab Lyophilized Powder for Infusion 150mg manufacturing, PCD franchise, or export inquiries, reach out today.

📧 Email: info@tajpharma.com
📱 Phone: +91 84484 44095
📲 WhatsApp: +91 7400009975 / +91 7400009976
🌐 Website: www.tajpharmaindia.com